Both in Pharmaceuticals
Apnimed vs Lexicon Pharmaceuticals
Over the past year APMD returned −28.3% and LXRX returned −30.3%; their daily moves had a correlation of 0.17.
APMD −28.3% LXRX −30.3%Growth of $1, one year, split-adjusted
| Metric | APMD | LXRX |
|---|---|---|
| Price | $18.81 | $1.40 |
| Market cap | $783.1M | $620.7M |
| Today | +1.51% | −6.38% |
| 1 month | −13.0% | −25.0% |
| 6 months | — | −17.0% |
| Year to date | — | +21.3% |
| 1 year | — | +0.4% |
| Revenue growth (YoY) | — | −97.6% |
| Gross margin | — | 94.4% |
| Net margin | — | −4591.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 15.0× |
| Net cash | — | $139.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 55.0% |
| Short % of float | 9.8% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).